Trials / Terminated
TerminatedNCT04574973
Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-stroke Hemiparesis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University of Kentucky · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Individuals who experienced a stroke over one year ago will be randomly assigned to receive 1 of 4 different conditions of brain stimulation. All individuals will receive therapy of the hand and arm following the stimulation. This study will try to determine which brain stimulation condition leads to the greatest improvement in hand and arm function.
Detailed description
This study will look at the effects of a painless, non-invasive form of brain stimulation, called transcranial direct current stimulation, or tDCS. tDCS is thought to increase the brain's ability to change. Participants will be assigned to one of four groups by chance. Three groups will receive tDCS at a level expected to increase the brain's ability to change, and will vary by the areas of the brain that are stimulated. The fourth group will receive tDCS at a level not thought to affect the brain's ability to change. All participants will receive intensive therapy of their impaired arm and hand, focusing on exercises that will improve their ability to function in daily life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transcranial direct current stimulation | This is a non-invasive form of stimulation which delivers safe, low levels of electrical current to the brain through the scalp. |
| BEHAVIORAL | intensive upper extremity motor training | This training is administered one-on-one with an occupational therapist. Activities will be focused on skills to help the individual function better in daily life. |
Timeline
- Start date
- 2018-11-28
- Primary completion
- 2021-01-08
- Completion
- 2021-01-08
- First posted
- 2020-10-05
- Last updated
- 2021-01-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04574973. Inclusion in this directory is not an endorsement.